Su CT, Nizialek E, Berchuck JE, Vlachostergios PJ, et al. Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. Prostate 2022 Nov 16. doi: 10.1002/pros.24454.
PMID: 36382533